| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | OF5P57N2ZX |
| InChI Key | QNAYBMKLOCPYGJ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C3H7NO2 |
| Molecular Weight | 89.09 |
| AlogP | -0.58 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 63.32 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 6.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | - | - | - | 5.399 | |
|
Enzyme
|
- | - | - | - | 100 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -21.28--3.75 | |
|
Ion channel
Ligand-gated ion channel
Ionotropic glutamate receptor
NMDA receptor
|
- | 198000 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC36 family of proton-coupled amino acid transporters
|
- | - | - | 2800000 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Fructose Intolerance | 2 | D005633 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 1 | D045169 | ClinicalTrials |
| Cognitive Dysfunction | 1 | D060825 | ClinicalTrials |
| Glioma | 1 | D005910 | ClinicalTrials |
| Alzheimer Disease | 1 | D000544 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 66916 |
| ChEMBL | CHEMBL12198 |
| DrugCentral | 4306 |
| EPA CompTox | DTXSID6031255 |
| FDA SRS | OF5P57N2ZX |
| Human Metabolome Database | HMDB0062251 |
| KEGG | C01401 |
| SureChEMBL | SCHEMBL31 |